Latest Coronavirus Disease COVID 19 News and Research
Number of heart attack patients has dropped over 50% during COVID-19 outbreak
The number of heart attack patients seeking urgent hospital care has dropped by more than 50% during the COVID-19 outbreak, according to an extensive worldwide survey by the European Society of Cardiology (ESC).
Teen vaping study identifies stomach issues and history of substance abuse
A study of teens diagnosed with the vaping-linked respiratory disease EVALI revealed that most also had gastrointestinal symptoms and a history of psychosocial factors, including substance abuse, UT Southwestern researchers found in one of the first clinical reviews of its kind.
ICUs become a ‘delirium factory’ for COVID patients
Doctors are fighting not only to save lives from COVID-19, but also to protect patients' brains.
Silent hypoxia and its role in COVID-19 detection
News-Medical speaks to Dr. Albet Rizzo about silent hypoxia and how it is occurring in individuals that are suffering from COVID-19.
Scientists map how SARS-CoV-2 infects the airways
Now, in a significant scientific study, a team of researchers at the University of North Carolina Health Care (UNC) have mapped how SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19), infects the nasal cavity, the airways, and down to the lungs.
_b80004f8b17f4df4b35c5441e6ea0596-150x125.jpg "Siemens receives FDA approval for SARS-CoV-2 antibody test")
Siemens receives FDA approval for SARS-CoV-2 antibody test
Siemens Healthineers has announced that the U.S. Food and Drug Administration (FDA) had issued an Emergency Use Authorization for its total antibody test to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, including Immunoglobulin M (IgM) and Immunoglobulin G (IgG) in the blood.
Does smoking increase COVID-19 risk?
The COVID-19 pandemic continues to smolder and smoke in many parts of the world, with over 100,000 cases, and more than 3,000 deaths reported every day. Many factors are responsible for the higher risk of infection in certain specific population subgroups are known.
Study shows Sofosbuvir alleviates COVID-19-related neurological symptoms
A group of researchers has studied the effects of an antiviral drug Sofosbuvir on human brain organoids infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Is it safe for SARS-CoV-2 positive mothers to breastfeed?
Even as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continues to cause thousands of cases every day, with many deaths, life continues to move on regardless. Births occur as usual, and in many countries, mothers prefer to breastfeed their babies, at least for the first few months of life.
Study looks at delirium in critically ill COVID-19 patients
A new study published on the online preprint server medRxiv in May 2020 reports on the high incidence of delirium in COVID-19 patients in intensive care. This highlights the urgent need to predict, prevent, and manage delirium and to cut it short in patients with COVID-19.
_40083af75acc45e398c53ae41e2a367e-150x125.jpg "A vectored vaccine candidate against SARS-CoV-2")
A vectored vaccine candidate against SARS-CoV-2
The current pandemic of COVID-19 is caused by the severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), a betacoronavirus similar to that which caused the SARS-CoV and MERS-CoV earlier. Scientists are pursuing therapeutic drugs and vaccines to counter the relentless spread of the virus, but so far, none has been established to be effective. However, several are in clinical trials in various parts of the world.
_f1422ee9f6724c81af184635c0498434-150x125.jpg "SARS-CoV-2 can adversely affect cardiac cells and heart function")
SARS-CoV-2 can adversely affect cardiac cells and heart function
A research group from Germany demonstrated a direct toxic effect of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on cardiac cells in their paper published on the bioRxiv* preprint server. The finding warrants an in-depth analysis of cardiac tissue in certain coronavirus disease (COVID-19) patients, as well as close monitoring for any direct cardiomyocyte injury.
_c760e24ffb474bdb8f49acc25408e17f-150x125.jpg "Cats resistant to SARS-CoV-2 reinfection")
Cats resistant to SARS-CoV-2 reinfection
Researchers at Colorado State University have made important discoveries about domestic cats infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could address concerns about human-to-animal transmission and the role domestic pets might play in spreading the virus.
Ozone disinfection of respirator masks for front-line workers coping with COVID-19
Researchers at Yale School of Medicine and collaborators have successfully used ozone to disinfect the respirator masks used by healthcare workers to protect against respiratory diseases such as coronavirus disease 2019 (COVID-19).
Scientists to develop device to identify neutralizing antibodies against SARS-CoV-2 infection
A Texas A&M University team of scientists and engineers is leading the development of a device that can be used to rapidly identify antibodies produced by human B cells that can neutralize infection by SARS-CoV-2, the causative agent of COVID-19.
SARS-CoV-2 infected patients who undergo surgery experience worse postoperative outcomes
Patients undergoing surgery after contracting coronavirus are at greatly increased risk of postoperative death, a new global study published in The Lancet reveals.
Study investigates outcome of COVID-19 infection in blood cancer patients
One of the first studies to investigate the outcome of COVID-19 infection in patients with blood cancer has been conducted by clinical researchers from Queen Mary University of London and Barts Health NHS Trust.
George Mason University researcher wins NSF RAPID grant to model virus spread
How a computer virus spreads gave George Mason University researcher Cameron Nowzari insight into how human viruses, like the coronavirus, spread.
Approach used against influenza epidemics could benefit COVID-19 drug development
A new study from researchers at The University of Texas at Austin has found that some antivirals are useful for more than helping sick people get better -- they also can prevent thousands of deaths and hundreds of thousands of virus cases if used in the early stages of infection.
A new tool to help biomedical scientists better understand COVID-19 virus
Biomedical scientists working with COVID-19 have a new tool to help them better understand the virus and feel confident about the structural models they are using in their research.
No hay comentarios:
Publicar un comentario